Cxense ASA: Sale of all shares in Mporium Group plc

Reference is made to the stock exchange notice made by Cxense ASA (“Cxense” or the “Company”) on 24 August 2017 regarding the new board and management’s decision to pursue a growth strategy with focus on DMP with Intelligent Personalization and to divest non-core business.

In line with this new strategy, the Company has today, on 1 November 2017, entered into agreements for sale of all its 113,123,403 shares in Mporium Group plc (“Mporium”), representing approximately 21.16% of the voting rights in Mporium, for net proceeds of GBP 2.83 million (USD 3.75 million). After this transaction Cxense will hold no shares in Mporium.

Alongside with the successful private placement of USD 5 million announced on 24 August 2017, the net proceeds of USD 3.75 million from the Mporium share sale represents solid funding of the new growth strategy focusing on DMP with Intelligent Personalization.

100 million (88%) of the Mporium shares were acquired by Cxense in May 2015 in connection with the Company and Mporium forming a strategic partnership, while the remaining shares have been acquired through the participation in two share issues. In total Cxense has invested USD 2.40 million in cash in Mporium.

Mporium is incorporated in England and Wales and its securities are traded on the AIM market of the London Stock Exchange. For information about Mporium, see the company’s webpage www.mporium.com.

The Mporium shares will be sold to a group of investors for a gross consideration of GBP 3.96 million and Cxense will, for the release of lock-up of 100 million of the shares, pay Mporium a lock-up release fee of GBP 1.13 million.

The current Cxense ASA (group parent) carrying book value of the Mporium investment is NOK 36.36 million (USD 4.44 million). For accounting purposes, the transaction will result in a net loss of USD 0.7 million.

The transaction is expected to be completed on or about 2 November 2017.

The Company is not aware of any agreements entered into or that are planned to be entered into, in connection with the transaction that are of the benefit for the senior employees or board of directors of the Company or for the senior employees or board of directors of Mporium.

Investor Relations Contact:

Jørgen Loeng, Chief Financial Officer

Email: ir@cxense.com

Mobile: +47 906 60 062

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.